Clinton's Choice For Top NSF Post: Can He Make The Agency `Sing'?

Colleagues and other scientists familiar with him describe theoretical physicist Neal F. Lane, President Bill Clinton's nominee for the directorship of the National Science Foundation, as "open-minded," "straightforward," and a "consensus-builder." They also say that these and other attributes of the Rice University provost will be necessary to defend and advance basic research as budgetary constraints tighten around the science agency. If confirmed, Lane, 54, will replace Walter E. Massey, wh

Written byRon Kaufman
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

If confirmed, Lane, 54, will replace Walter E. Massey, who left the foundation last March after a two-year stint to become senior vice president for academic affairs and provost for the University of California system. NSF, with an annual budget of nearly $3 billion, is one of the major sources for individual- investigator grants in the basic sciences.

Presidential science adviser John Gibbons, who assisted the White House personnel office in its search to replace Massey, says Lane's academic background as well as the year he spent as director of NSF's physics division (1979-80) give him the well- rounded experience needed to head the agency.

"I admire him and am delighted he's willing to come to Washington and help turn the commitments of this administration toward the continued strong support of basic science," says Gibbons. "And I hope he will provide the kind of leadership and energy within the NSF ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies